Clinical Trials Directory

Trials / Completed

CompletedNCT00374582

End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Cincinnati · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)

Detailed description

The aim of this study is to report the validity of mBIA to determine body composition changes pre and post LVP (Large Volume Paracentesis) * 18 years of age or older * Cirrhotic patients with refractory ascites requiring LVP (a treatment to remove large volumes of excess fluid from the abdominal cavity) * End Stage Liver Disease

Conditions

Interventions

TypeNameDescription
DEVICEBodystat Quadscan 4000device determining body composition and nutritional status
DEVICEbodystat quadscan 400device determining body composition and nutritional status

Timeline

Start date
2006-09-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2006-09-11
Last updated
2011-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00374582. Inclusion in this directory is not an endorsement.